The burgeoning field of cardio-oncology (C-O) is now necessary for the delivery of excellent care for patients with cancer. Many factors have contributed to this increasing population of cancer survivors or those being treated with novel and targeted cancer therapies. There is a tremendous need to provide outstanding cardiovascular (CV) care for these patients; however, current medical literature actually provides a paucity of guidance. C-O therefore provides a novel opportunity for clinical, translational, and basic research to advance patient care. This review aims to be a primer for cardio-oncologists on how to develop a vibrant and comprehensive C-O program, use practical tools to assist in the construction of C-O services, and to proactively incorporate translational and clinical research into the training of future leaders as well as enhance clinical care.
Bibliographical noteFunding Information:
The authors report no relevant conflicts for this manuscript with the exception of DL who has received research funding from Myocardial Solutions, Inc. and has modest consultant arrangements with Roche, Bristol-Myers Squibb, and Pfizer.
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
Copyright 2020 Elsevier B.V., All rights reserved.
- Practice excellence
- Program development
- Translational research
PubMed: MeSH publication types
- Journal Article